UVC-360

UVC Disinfection in the OR Setting

Posted by Tru-D SmartUVC 04.03.19

Hospital Resources – OR ImageWith AORN quickly approaching, we wanted to share some updated information on SSIs and UVC disinfection in the OR setting.

In 2014, a total of 14.2 million operative procedures were performed in the inpatient setting in United States hospitals. Even more, SSIs are the costliest HAI type with an estimated annual cost of $3 billion to $10 billion annually and are associated with nearly 1 million additional inpatient days annually.

Tru-D has been shown to provide a cleaner, safer operating environment. A recent manuscript accepted by the Journal of the American College of Surgeons examined C. diff in adult surgical patients.  The paper, “Multidisciplinary Approach and Clostridium difficile Infection in Adult Surgical Patients,” discusses the multidisciplinary program that Duke University Medical Center implemented to reduce its postoperative C. diff rate.

Strategies to reduce CDI included antimicrobial stewardship optimization, increased use of Tru-D SmartUVC for terminal cleaning of CDI patient rooms, increased hand hygiene and PPE signage as well as monitoring in high-risk CDI areas, improved diagnostic stewardship by an electronic best practice advisory to reduce inappropriate CDI testing, education through surgical grand rounds and routine data feedback via NSQIP and NHSN CDI reports.

Using these strategies, observed rate of C. diff decreased from 1.27 percent in 2016 to 0.91 percent in 2017, a 28 percent decrease. Individual hospital results vary. The BETR-D randomized clinical trial showed a cumulative 30 percent reduction in the relative risk of colonization and infection when paired with 93 percent compliance with standard disinfection protocols. Click for more details.

Tru-D has also been shown to reduce bioburden on anesthesia workstations. A study was conducted at Virginia Commonwealth University (VCU) to assess organism killing on complex medical devices in difficult-to-access, high-touch areas that included dials, knobs and handles that are challenging to clean manually. All trials, compared with the controls, exhibited significant bioburden reduction. The research team went on to suggest that Tru-D’s technology is an important supplement to the manual cleaning process.

Individual hospital results may vary based on adherence to standard disinfection protocol.

Visit us to at AORN in booth #1738 to learn how we can help improve patient outcomes and reduce SSIs. To learn more about Tru-D’s technology in the OR, click here.

Posted 04.03.19
  • Share

Never miss the latest in UV news.
Subscribe to UVC360 today.

Sign Up »